Filings · 2026-09-24

Thu, Sep 24

Filings that arrived on this Korea-time day

checked 10/4 22:05 KST · Filings arrive within legal deadlines (Form 4: 2 business days after the trade; 13D: 5 business days; 13G: up to 45 days after quarter end). Dates shown are filing dates, not trade dates.

US insiders reported 3 open-market buys ($12.0M) and 15 sales ($27.2M). 13 Schedule 13D/13G filings, 1 of them first-time 13D.

3Insider buys

15Insider sales

13US 13D/13G

Stocks several insiders bought

2+ insiders · last 30 days

Stock	Insiders	Bought ($)	Last trade
CapsoVision today CV	2	15.0M	9/18
Bank Bradesco BBD · same date and price (often a company programme)	21	27.0M	9/18
Star Bulk Carriers SBLK · same date and price (often a company programme)	4	4.9M	9/15
Cpi Card Group PMTS · same date and price (often a company programme)	3	11.8M	9/14
Cybin CYBN	2	8.3M	9/8
Carparts.Com PRTS	2	1.5M	9/9
Venu Holding VENU	2	0.7M	9/11
Redwood Trust RWT	2	0.6M	9/16

Stock

Insiders

Bought ($)

Last trade

CapsoVision today

15.0M

9/18

Bank Bradesco

BBD · same date and price (often a company programme)

27.0M

9/18

Star Bulk Carriers

SBLK · same date and price (often a company programme)

4.9M

9/15

Cpi Card Group

PMTS · same date and price (often a company programme)

11.8M

9/14

Cybin

CYBN

8.3M

9/8

Carparts.Com

PRTS

1.5M

9/9

Venu Holding

VENU

0.7M

9/11

Redwood Trust

RWT

0.6M

9/16

Open-market purchases of $250K or more reported on Form 4. Several insiders buying is a reported fact, not a forecast.

Largest insider buys

SEC Form 4

Stock	Insider	Trade	Amount ($)	Traded
CapsoVision CVEliyahou Et Al Harari · 10% owner	Eliyahou Et Al Harari 10% owner	Buy	10.0M	9/18
Kayne Anderson BDC KBDCJames L Robo · Director	James L Robo Director	Buy	1.5M	9/23
Inhibrx Biosciences INBXJon Faiz Kayyem · Director	Jon Faiz Kayyem Director	Buy	0.5M	9/23

Stock

Insider

Trade

Amount ($)

Traded

CapsoVision

CVEliyahou Et Al Harari · 10% owner

Eliyahou Et Al Harari

10% owner

Buy

10.0M

9/18

Kayne Anderson BDC

KBDCJames L Robo · Director

James L Robo

Director

Buy

1.5M

9/23

Inhibrx Biosciences

INBXJon Faiz Kayyem · Director

Jon Faiz Kayyem

Director

Buy

0.5M

9/23

First-time 13D filings

active stakes over 5%

Stock	Holder	Stake	Change	Filed
Ursb Bancorp URSBSeidman & Associates LLC Et Al	Seidman & Associates LLC Et Al Active	2.2%	New filing	9/23

Stock

Holder

Stake

Change

Filed

Ursb Bancorp

URSBSeidman & Associates LLC Et Al

Seidman & Associates LLC Et Al

Active

2.2%

New filing

9/23

Largest insider sales

SEC Form 4

Stock	Insider	Trade	Amount ($)	Traded
Datadog DDOGDavid M Obstler · CFO	David M Obstler CFO	Sell Plan	3.9M	9/21
Oracle ORCLMichael D. Sicilia · CEO	Michael D. Sicilia CEO	Sell Plan	3.4M	9/22
Arm Holdings PLC /Uk ARMJason Child · CFO	Jason Child CFO	Sell Plan	3.1M	9/21
Qualcomm Inc/De QCOMCristiano R Amon · CEO	Cristiano R Amon CEO	Sell Plan	1.9M	9/21
Ati ATITimothy J Harris · Senior VP and CDIO	Timothy J Harris Senior VP and CDIO	Sell Plan	1.7M	9/21

Stock

Insider

Trade

Amount ($)

Traded

Datadog

DDOGDavid M Obstler · CFO

David M Obstler

CFO

Sell Plan

3.9M

9/21

Oracle

ORCLMichael D. Sicilia · CEO

Michael D. Sicilia

CEO

Sell Plan

3.4M

9/22

Arm Holdings PLC /Uk

ARMJason Child · CFO

Jason Child

CFO

Sell Plan

3.1M

9/21

Qualcomm Inc/De

QCOMCristiano R Amon · CEO

Cristiano R Amon

CEO

Sell Plan

1.9M

9/21

Ati

ATITimothy J Harris · Senior VP and CDIO

Timothy J Harris

Senior VP and CDIO

Sell Plan

1.7M

9/21

Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.